$841 Million is the total value of Iron Triangle Partners LP's 28 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 61.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ICLR | Buy | ICON PLC | $65,074,000 | +91.0% | 267,551 | +143.2% | 7.74% | +63.1% |
HZNP | Buy | HORIZON THERAPEUTICS PUB L | $52,999,000 | +107.1% | 503,744 | +112.1% | 6.30% | +76.8% |
GH | Buy | GUARDANT HEALTH INC | $47,834,000 | +8.6% | 722,126 | +64.0% | 5.69% | -7.3% |
UNH | Buy | UNITEDHEALTH GROUP INC | $45,904,000 | +52.4% | 90,014 | +50.0% | 5.46% | +30.1% |
CTLT | Buy | CATALENT INC | $43,546,000 | +7.4% | 392,663 | +24.0% | 5.18% | -8.3% |
NVRO | Buy | NEVRO CORP | $40,710,000 | +18.9% | 562,833 | +33.3% | 4.84% | +1.5% |
ILMN | New | ILLUMINA INC | $38,434,000 | – | 110,000 | +100.0% | 4.57% | – |
HOLX | Buy | HOLOGIC INC | $36,874,000 | +72.0% | 480,000 | +71.4% | 4.39% | +46.8% |
DXCM | New | DEXCOM INC | $35,812,000 | – | 70,000 | +100.0% | 4.26% | – |
UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $34,101,000 | -7.2% | 190,073 | +11.8% | 4.06% | -20.8% |
MOH | Buy | MOLINA HEALTHCARE INC | $33,359,000 | +7.1% | 100,000 | +2.2% | 3.97% | -8.6% |
HQY | New | HEALTHEQUITY INC | $32,834,000 | – | 486,862 | +100.0% | 3.90% | – |
ICUI | Buy | ICU MED INC | $30,349,000 | +11.7% | 136,313 | +19.0% | 3.61% | -4.7% |
AZN | New | ASTRAZENECA PLCsponsored adr | $25,209,000 | – | 380,000 | +100.0% | 3.00% | – |
CNMD | Buy | CONMED CORP | $23,847,000 | +12.3% | 160,530 | +7.2% | 2.84% | -4.1% |
ALGN | Buy | ALIGN TECHNOLOGY INC | $21,800,000 | -17.1% | 50,000 | +25.0% | 2.59% | -29.2% |
GDRX | New | GOODRX HLDGS INC | $21,063,000 | – | 1,089,677 | +100.0% | 2.50% | – |
SGEN | New | SEAGEN INC | $18,727,000 | – | 130,000 | +100.0% | 2.23% | – |
KPTI | New | KARYOPHARM THERAPEUTICS INC | $14,740,000 | – | 2,000,000 | +100.0% | 1.75% | – |
Buy | SOMALOGIC INC | $14,195,000 | -15.2% | 1,770,000 | +23.2% | 1.69% | -27.6% | |
MASS | New | 908 DEVICES INC | $13,556,000 | – | 713,105 | +100.0% | 1.61% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
SURGERY PARTNERS INC | 11 | Q2 2023 | 6.4% |
ICON PLC | 10 | Q3 2023 | 11.7% |
BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
NEVRO CORP | 10 | Q1 2022 | 6.7% |
DEXCOM INC | 10 | Q3 2023 | 7.7% |
ABBVIE INC | 9 | Q3 2023 | 8.1% |
ACADIA HEALTHCARE COMPANY IN | 9 | Q3 2023 | 7.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.